Pilot Study of Gut Commensals in Antiphospholipid Syndrome | MicrobiomeTrials← Back to trialsNCT01787305
Pilot Study of Gut Commensals in Antiphospholipid Syndrome
CompletedOBSERVATIONAL
Trial Details
Start: 2013-02Est. Completion: 2017-01
Enrollment target: 16 participants Locations- Yale University School of Medicine; Yale-New Haven Hospital, New Haven, Connecticut, United States
Other microbiome trials you might be interested in
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory MyopathyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntiphospholipid Syndrome (APS)Rheumatoid Arthritis (RA)IgG4-Related DiseasesSjogren's Syndrome
This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, suc…
Beijing, ChinaEst. completion May 19, 2027
The purpose of this study is to see if the study medication, daratumumab, is safe to treat individuals with Anti-Phospho…
Baltimore, United StatesEst. completion May 5, 2028
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)Inflammatory MyopathyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntiphospholipid Syndrome (APS)
This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, suc…
Tianjin, ChinaEst. completion Aug 13, 2027